Physician profile
Steven Edens
NPI 1215468863
$6,795.31
in general payments reported to CMS, 2019-2025
25 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $586 · 2023: $1,162 · 2024: $3,087 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,639 · Travel and Lodging: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,638.92 |
| Travel and Lodging | $1,271.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,450.57 | 2023-2025 | Lensx, Hydrus Microstent, Clareon |
| Abbvie INC. | $768.25 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Bausch & Lomb Americas INC. | $667.39 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $572.20 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $320.91 | 2024-2025 | Vevye, Triesence, Iheezo |
| Sun Pharmaceutical Industries INC. | $282.86 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $209.39 | 2021-2023 | Tecnis Simplicity, Tecnis Iol |
| Dompe US, INC. | $195.54 | 2021-2025 | Oxervate |
| Sight Sciences, INC. | $191.62 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Regeneron Healthcare Solutions, INC. | $153.75 | 2024 | Eylea Hd, Eylea |
| Novartis Pharmaceuticals Corporation | $150.01 | 2022-2023 | |
| Allergan, INC. | $109.15 | 2021-2022 | |
| Genentech USA, INC. | $107.47 | 2024-2025 | Vabysmo |
| New World Medical,INC. | $104.77 | 2023 | |
| Glaukos Corporation | $81.85 | 2022-2025 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idosetr, Istent Infinite |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $78.60 | 2025 | Ryzumvi, Tyrvaya |
| Apellis Pharmaceuticals, INC. | $77.94 | 2023-2025 | Syfovre |
| Eyevance Pharmaceuticals LLC | $75.99 | 2022 | |
| Astellas Pharma US INC | $52.27 | 2024 | Izervay |
| Oculus Surgical INC. | $37.81 | 2024 | |
| Mallinckrodt Hospital Products INC. | $31.73 | 2021 | |
| Ani Pharmaceuticals, INC. | $23.80 | 2024 | Purified Cortrophin Gel |
| Kala Pharmaceuticals, INC. | $17.79 | 2021 | |
| Coopervision INC. | $17.58 | 2024 | Myday Contact Lens |
| Pacira Pharmaceuticals Incorporated | $16.07 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Edens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.